NASDAQ:CLDX
$33.19
(
3.30%
)
Friday, 2nd Jun 2023
Celldex Therapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $30.26 | $35.74 | Friday, 2nd Jun 2023 CLDX stock ended at $33.19. This is 3.3% more than the trading day before Thursday, 1st Jun 2023. During the day the stock fluctuated 4.13% from a day low at $31.93 to a day high of $33.25. |
| 90 days | $29.68 | $46.98 | |
| 52 weeks | $19.85 | $48.40 |
Historical Celldex Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2023-06-02 | $32.68 | $33.25 | $31.93 | $33.19 | 369 474 |
| 2023-06-01 | $31.80 | $32.50 | $31.28 | $32.13 | 254 659 |
| 2023-05-31 | $31.29 | $32.61 | $30.88 | $31.80 | 357 269 |
| 2023-05-30 | $31.14 | $31.30 | $30.50 | $31.18 | 275 865 |
| 2023-05-26 | $30.40 | $31.02 | $30.28 | $30.57 | 244 761 |
| 2023-05-25 | $31.92 | $32.36 | $30.26 | $30.37 | 328 590 |
| 2023-05-24 | $32.41 | $32.71 | $31.86 | $32.01 | 352 899 |
| 2023-05-23 | $33.64 | $34.24 | $32.72 | $32.74 | 428 299 |
| 2023-05-22 | $33.08 | $33.77 | $33.06 | $33.62 | 258 683 |
| 2023-05-19 | $31.78 | $32.92 | $31.71 | $32.89 | 404 773 |
| 2023-05-18 | $31.87 | $32.14 | $30.66 | $31.29 | 483 476 |
| 2023-05-17 | $33.42 | $33.61 | $32.14 | $32.18 | 336 950 |
| 2023-05-16 | $33.52 | $33.90 | $33.00 | $33.25 | 489 542 |
| 2023-05-15 | $34.53 | $35.74 | $34.07 | $34.26 | 269 911 |
| 2023-05-12 | $33.10 | $34.40 | $32.58 | $34.35 | 299 438 |
| 2023-05-11 | $33.27 | $33.99 | $32.96 | $33.07 | 348 243 |
| 2023-05-10 | $33.57 | $33.77 | $32.88 | $33.57 | 294 827 |
| 2023-05-09 | $32.95 | $33.28 | $32.44 | $33.13 | 350 230 |
| 2023-05-08 | $33.37 | $33.59 | $32.99 | $33.36 | 464 955 |
| 2023-05-05 | $31.52 | $33.91 | $31.52 | $33.28 | 660 566 |
| 2023-05-04 | $30.90 | $31.92 | $30.49 | $31.49 | 514 285 |
| 2023-05-03 | $31.06 | $32.64 | $31.06 | $31.46 | 566 530 |
| 2023-05-02 | $31.19 | $31.67 | $30.44 | $30.85 | 697 837 |
| 2023-05-01 | $31.51 | $32.31 | $31.28 | $31.35 | 502 423 |
| 2023-04-28 | $31.41 | $31.50 | $30.60 | $31.44 | 509 590 |
| 2023-04-27 | $32.29 | $33.18 | $31.58 | $31.73 | 525 378 |
| 2023-04-26 | $33.89 | $34.06 | $32.05 | $32.33 | 434 420 |
| 2023-04-25 | $34.66 | $35.47 | $33.78 | $33.98 | 412 270 |
| 2023-04-24 | $36.51 | $36.76 | $34.68 | $34.73 | 398 648 |
| 2023-04-21 | $35.88 | $36.98 | $35.58 | $36.62 | 568 677 |
| 2023-04-20 | $36.37 | $36.50 | $35.24 | $35.89 | 600 456 |
| 2023-04-19 | $34.16 | $36.88 | $33.58 | $36.45 | 794 043 |
| 2023-04-18 | $32.55 | $34.55 | $32.08 | $34.37 | 838 139 |
| 2023-04-17 | $30.35 | $33.19 | $30.35 | $32.45 | 1 791 613 |
| 2023-04-14 | $31.31 | $31.59 | $29.68 | $30.29 | 1 144 739 |
| 2023-04-13 | $31.08 | $31.91 | $31.08 | $31.55 | 1 960 602 |
| 2023-04-12 | $31.68 | $31.73 | $30.79 | $30.96 | 846 654 |
| 2023-04-11 | $31.69 | $32.20 | $31.27 | $31.41 | 435 814 |
| 2023-04-10 | $32.18 | $32.32 | $30.74 | $31.50 | 1 006 960 |
| 2023-04-06 | $33.18 | $33.61 | $32.06 | $32.40 | 893 612 |
| 2023-04-05 | $35.12 | $35.36 | $33.17 | $33.18 | 979 203 |
| 2023-04-04 | $35.74 | $36.09 | $34.73 | $35.30 | 722 143 |
| 2023-04-03 | $35.54 | $37.30 | $35.51 | $35.81 | 614 495 |
| 2023-03-31 | $35.91 | $36.15 | $35.19 | $35.98 | 572 785 |
| 2023-03-30 | $36.17 | $36.18 | $34.81 | $35.58 | 512 617 |
| 2023-03-29 | $35.42 | $36.12 | $34.61 | $35.96 | 400 353 |
| 2023-03-28 | $35.03 | $35.81 | $34.39 | $34.78 | 882 958 |
| 2023-03-27 | $36.51 | $36.77 | $35.03 | $35.20 | 495 830 |
| 2023-03-24 | $34.59 | $36.87 | $33.83 | $36.56 | 861 942 |
| 2023-03-23 | $36.56 | $36.56 | $34.96 | $35.10 | 1 176 276 |
About Celldex Therapeutics
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
